Elicio Therapeutics (ELTX) Stock Price, Quote, News & History | Benzinga

Elicio Therapeutics Inc (ELTX) Stock Price, Quote, News & History

ELTXNASDAQ

Trade with Public

Trade with Public

$3.11

0.092.98%

At close: Aug 18, 5:00 PM EST

$3.10

-0.01-0.32%

After Hours: 4:29 PM EST

Earnings: Q2 2026 Earnings were released on Thu Aug 13th, after the market close

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$3.03

Close

$3.11

Volume / Avg.

389.10K / 1.67M

Day Range

$2.98 - $3.12

52 Wk Range

2.66 - 16.00

Market Cap

$81.47M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

8.57%

Days to Cover

5.07

Recent Elicio Therapeutics Inc News

Why Smith & Wesson Brands Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Smith & Wesson (SWBI) shares rose in pre-market trading after posting strong Q4 results, beating earnings and revenue estimates. Other gainers include LNKS, ADTX, and SPRO.

Avi Kapoor

Elicio Therapeutics Points To Durable Responses As It Maps Next Steps For Lead Cancer Drug

Elicio shares complete response data for ELI-002 7P in KRAS pancreatic cancer and plans combination studies after mixed Phase 2 results.

Vandana Singh

Elicio Therapeutics Pancreatic Cancer Study Disappoints

Elicio Therapeutics reports mixed Phase 2 pancreatic cancer results, identifies key patient subgroup benefit, and outlines Phase 3 plans.

Vandana Singh

Crude Oil Tumbles Over 5%; Empire State Manufacturing Index Falls In June

US stocks gain on peace agreement with Iran, Nasdaq up 2%, Dow up 1.1%, S&P 500 up 1.54%. Tech shares jump 2.8%, energy stocks fall 3.5%. Empire State manufacturing index drops to 5.7. Industrial production up 0.1%. Housing market index declines to 35.

Avi Kapoor

Dow Jumps Over 600 Points Following US-Iran Peace Deal

US stocks rise on peace agreement with Iran, Dow up 600 points. Tech sector jumps, energy stocks down. Trump announces deal, oil futures decline.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-37.69M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

38.97M

Free Cash Flow (TTM)

-37.71M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

1.26M

Analyst Trends and Forecast

2

Mar

1

Apr

1

May

3

Jun

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$72.40M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

10.30

Earnings Yield % (TTM)

-69.13%

Earnings Yield % (FWD)

-58.52%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.30

Company Debt

Total Debt

$9.54M

LT Debt

$9.54M

LT Debt Issuance (TTM)

-$9.87M

LT Debt Repayment (TTM)

-

Total Cash

$23.48M

Debt to Equity

1.78

Issuance of Debt (TTM)

-$9.87M

Repayment of Debt (TTM)

-

Key Statistics

Open

$3.03

Close

$3.11

Volume / Avg.

389.10K / 1.67M

Day Range

$2.98 - $3.12

52 Wk Range

2.66 - 16.00

Market Cap

$81.47M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

8.57%

Days to Cover

5.07

About

Sector

Health Care

Industry

Biotechnology

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Com...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Elicio Therapeutics (ELTX) stock?

A

You can purchase shares of Elicio Therapeutics (NASDAQ:ELTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Elicio Therapeutics (ELTX) competitors?

A

Other companies in Elicio Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Elicio Therapeutics (ELTX) stock?

A

Elicio Therapeutics has a consensus price target of $18.00.

Q

What is the current price for Elicio Therapeutics (ELTX)?

A

The stock price for Elicio Therapeutics (NASDAQ: ELTX) is $3.1 last updated August 18, 2026 at 4:29 PM EDT.

Q

Does Elicio Therapeutics (ELTX) pay a dividend?

A

There are no upcoming dividends for Elicio Therapeutics.

Q

When is Elicio Therapeutics (NASDAQ:ELTX) reporting earnings?

A

Elicio Therapeutics does not have any upcoming earnings scheduled.

Q

Is Elicio Therapeutics (ELTX) going to split?

A

There is no upcoming split for Elicio Therapeutics.

Q

What sector and industry does Elicio Therapeutics (ELTX) operate in?

A

Elicio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.